These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 2642977)

  • 1. Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation.
    Hinds P; Finlay C; Levine AJ
    J Virol; 1989 Feb; 63(2):739-46. PubMed ID: 2642977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p53 proto-oncogene can act as a suppressor of transformation.
    Finlay CA; Hinds PW; Levine AJ
    Cell; 1989 Jun; 57(7):1083-93. PubMed ID: 2525423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life.
    Finlay CA; Hinds PW; Tan TH; Eliyahu D; Oren M; Levine AJ
    Mol Cell Biol; 1988 Feb; 8(2):531-9. PubMed ID: 2832726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological evidence for the association of p53 with a heat shock protein, hsc70, in p53-plus-ras-transformed cell lines.
    Hinds PW; Finlay CA; Frey AB; Levine AJ
    Mol Cell Biol; 1987 Aug; 7(8):2863-9. PubMed ID: 3313006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The p53 tumor suppressor gene and gene product.
    Levine AJ
    Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simian virus 40 large T antigen contains two independent activities that cooperate with a ras oncogene to transform rat embryo fibroblasts.
    Cavender JF; Conn A; Epler M; Lacko H; Tevethia MJ
    J Virol; 1995 Feb; 69(2):923-34. PubMed ID: 7815561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation of p53 cellular tumour antigen in transformation of normal embryonic cells.
    Eliyahu D; Raz A; Gruss P; Givol D; Oren M
    Nature; 1984 Dec 13-19; 312(5995):646-9. PubMed ID: 6095116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mutant p53 protein is required for maintenance of the transformed phenotype in cells transformed with p53 plus ras cDNAs.
    Zambetti GP; Olson D; Labow M; Levine AJ
    Proc Natl Acad Sci U S A; 1992 May; 89(9):3952-6. PubMed ID: 1570319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cellular oncogene p53 can be activated by mutagenesis.
    Jenkins JR; Rudge K; Chumakov P; Currie GA
    Nature; 1985 Oct 31-Nov 6; 317(6040):816-8. PubMed ID: 3903515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes.
    Hinds PW; Finlay CA; Quartin RS; Baker SJ; Fearon ER; Vogelstein B; Levine AJ
    Cell Growth Differ; 1990 Dec; 1(12):571-80. PubMed ID: 2288874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperation of p53 and polyoma virus middle T antigen in the transformation of primary rat embryo fibroblasts.
    Reihsaus E; Kraiss S; Barnekow A; Montenarh M
    Exp Cell Res; 1992 Mar; 199(1):10-8. PubMed ID: 1735451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immortalization of rat embryo fibroblasts by the cellular p53 oncogene.
    Rovinski B; Benchimol S
    Oncogene; 1988 May; 2(5):445-52. PubMed ID: 3287278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A modified p53 overcomes mdm2-mediated oncogenic transformation: a potential cancer therapeutic agent.
    Lin J; Jin X; Page C; Sondak VK; Jiang G; Reynolds RK
    Cancer Res; 2000 Oct; 60(20):5895-901. PubMed ID: 11059788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wild-type p53 can inhibit oncogene-mediated focus formation.
    Eliyahu D; Michalovitz D; Eliyahu S; Pinhasi-Kimhi O; Oren M
    Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8763-7. PubMed ID: 2530586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth.
    Finlay CA
    Mol Cell Biol; 1993 Jan; 13(1):301-6. PubMed ID: 8417333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53-plus-ras-transformed rat embryo fibroblasts express tumor-specific transplantation antigen activity which is shared by independently transformed cells.
    Frey AB; Levine AJ
    J Virol; 1989 Dec; 63(12):5440-4. PubMed ID: 2531235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of oncogene cooperation: activation and inactivation of a growth antagonist.
    Ragozzino MM; Kuo A; DeGregori J; Kohl N; Ruley HE
    Environ Health Perspect; 1991 Jun; 93():97-103. PubMed ID: 1837777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of normal human p53 in established fibroblasts leads to their tumorigenic conversion.
    Tuck SP; Crawford L
    Oncogene Res; 1989; 4(2):81-96. PubMed ID: 2654816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoplastic transformation of normal rat embryo fibroblasts by a mutated p53 and an activated ras oncogene induces parathyroid hormone-related peptide gene expression and causes hypercalcemia in nude mice.
    Motokura T; Endo K; Kumaki K; Ogata E; Ikeda K
    J Biol Chem; 1995 Dec; 270(52):30857-61. PubMed ID: 8537338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental metastasis in nude mice of NIH 3T3 cells containing various ras genes.
    Bradley MO; Kraynak AR; Storer RD; Gibbs JB
    Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5277-81. PubMed ID: 3523488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.